INVO Bioscience Inc (INVO)
0.8941
-0.02
(-2.21%)
USD |
NASDAQ |
May 22, 16:00
0.8905
0.00 (0.00%)
After-Hours: 20:00
INVO Bioscience Revenue (Annual): 3.021M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.021M |
| December 31, 2022 | 0.8222M |
| December 31, 2021 | 4.160M |
| December 31, 2020 | 1.037M |
| December 31, 2019 | 1.480M |
| December 31, 2018 | 0.4944M |
| December 31, 2017 | 0.2821M |
| December 31, 2016 | 0.0509M |
| Date | Value |
|---|---|
| December 31, 2015 | 0.0117M |
| December 31, 2014 | 0.0166M |
| December 31, 2013 | 0.0271M |
| December 31, 2012 | 0.0564M |
| December 31, 2011 | 0.0715M |
| December 31, 2010 | 0.0676M |
| December 31, 2009 | 0.0632M |
| December 31, 2008 | 0.038M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
0.8222M
Minimum
2022
4.160M
Maximum
2021
2.104M
Average
1.480M
Median
2019
Revenue (Annual) Benchmarks
| Abbott Laboratories | 40.11B |
| Perspective Therapeutics Inc | -- |
| Xtant Medical Holdings Inc | 91.30M |
| Asensus Surgical Inc | 8.577M |
| Catheter Precision Inc | 0.442M |